262202 Best practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment: Lessons from the Infertility Prevention Project (IPP)

Wednesday, October 31, 2012 : 10:30 AM - 10:45 AM

Sarah Goldenkranz, MPH , Cardea Services, Seattle, WA
David Fine, PhD , Cardea Services, Seattle, WA
Jennifer Curtiss, MEd , Cardea Services, Austin, TX
Wendy Nakatsukasa-Ono, MPH , Cardea Services, Seattle, WA
Allison Atterberry, RN, BSN , Cardea Services, Austin, TX
Background: IPP provides CT/GC screening and treatment of females at family planning, STD and other clinics nationally. Regional infrastructures facilitate translating research to practice. This overview describes IPP implementation and evaluation results from 5 of the most impactful innovations that improved case detection and cost-effectiveness. 1: Screen teenage women. Teens are at highest-risk for CT, yet fewer than 50% are screened annually at FP clinics. Changing clinical protocols and clinic testing caps increased screening of young women and reduced screening of older women. Targeted adolescent testing can increase case detection by 30%. 2: Self-collected specimens. Vaginal swabs improve clinic efficiency, screening coverage, and diagnostic capability. IPP developed free tools for clinicians and clients to promote vaginal swabs and documented rapid uptake of vaginal swab use. 3: Re-testing. Women should be retested after chlamydial infection due to increased risk of re-infection and sequelae. Evaluation showed Individual- and systems-level interventions are needed to improve patient return rates and provider re-testing practices. 4: Pooling Samples. Labs can combine multiple specimens from clinics with low CT/GC positivity, resulting in cost-savings and processing efficiencies. 5: Expedited Partner Therapy. EPT is when CT/GC-infected patients receive antibiotic medications to give to sex partners. Evaluation documents implementation successes and challenges, including clinical protocol development, and clinician attitudes and practices. Conclusion: With 20+ years' experience and evaluation data, IPP is a resource about best practices in CT/GC screening and treatment. These five innovations are important for those engaged in the field and concerned with efficient, effective program practices.

Learning Areas:
Administration, management, leadership
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Program planning
Provision of health care to the public
Public health or related organizational policy, standards, or other guidelines

Learning Objectives:
Describe 5 innovations for improving case-detection and cost-effectiveness of chlamydia and gonorrhea screening. Articulate where to look for additional resources and information on innovations and evaluations available from the Infertility Prevention Project.

Keywords: Chlamydia, Screening

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Data Manager for the Region VI and Region X Infertility Prevention Project, which provides chlamydia screening and treatment throughout the United States. I have authored several of the studies that will be described in this presentation.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.